Prostate Cancer Market Analysis

The total prevalent cases of Prostate Cancer in the 7MM is expected to be 7,494,882 in 2020.

The market size of Prostate Cancer is expected to grow at a CAGR of 8.1% during the study period 2017-2030.

AstraZeneca, Bristol-Myers Squibb, Novartis, Myovant Sciences, Janssen Research & Development, Hinova Pharmaceuticals USA, Hoffmann-La Roche, Pfizer/Astellas Pharma, Clovis Oncology, Advantagene, and Merck Sharp & Dohme along with others are the major pharma companies working to fuel the Prostate Cancer market.

For more detailed information on Prostate Cancer Market, visit: https://www.delveinsight.com/report-store/prostate-cancer-market